Characterising potential bone scan overuse amongst men treated with radical prostatectomy

Author:

Kirk Peter S.1ORCID,Borza Tudor1,Caram Megan E.V.23,Shumway Dean A.4,Makarov Danil V.56,Burns Jennifer A.3,Shelton Jeremy B.7,Leppert John T.89,Chapman Christina34,Chang Michael10,Hollenbeck Brent K.1,Skolarus Ted A.13ORCID

Affiliation:

1. Dow Division of Health Services Research; Department of Urology; University of Michigan Health System; Ann Arbor MI USA

2. Division of Hematology and Oncology; Department of Internal Medicine; University of Michigan Health System; Ann Arbor MI USA

3. VA Health Services Research and Development; Center for Clinical Management Research; VA Ann Arbor Healthcare System; Ann Arbor MI USA

4. Department of Radiation Oncology; University of Michigan Health System; Ann Arbor MI USA

5. Departments of Urology and Population Health; NYU Langone Medical Center; New York NY USA

6. Veterans Affairs (VA) New York Healthcare System; New York NY USA

7. VA Greater Los Angeles Healthcare System; Los Angeles CA USA

8. Department of Urology; Stanford University School of Medicine; Stanford CA USA

9. VA Palo Alto Healthcare System; Palo Alto CA USA

10. Hunter Holmes McGuire VA Medical Center; Richmond VA USA

Funder

Ruth L. Kirschstein National Research Service Award

National Cancer Institute

National Institutes of Health

Agency for Healthcare Research and Quality

Health Services Research and Development

Publisher

Wiley

Subject

Urology

Reference33 articles.

1. National Comprehensive Cancer Network Practice Guidelines in Oncology: Prostate Cancer v2 https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

2. American Urological Association PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer: 2013 Revision of 2009 Best Practice Statement https://auanet.org/documents//education/clinical-guidance/Prostate-Specific-Antigen.pdf

3. Baseline staging of newly diagnosed prostate cancer: a summary of the literature;Abuzallouf;J Urol,2004

4. Overuse of imaging for staging low risk prostate cancer;Choi;J Urol,2011

5. Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer;Falchook;J Oncol Pract,2015

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3